Harmon Seth

USNatural personCFO

Insider

Harmon Seth

USNatural personCFO

Transactions

Issuers

Buys / Sells

0/0

Last tx

03 Mar 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Viridian Therapeutics, Inc.\DE	18,801	reported	03 Mar 2026	tx 9+575,142−10,389

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
03 Mar 2026	EXERCISE	Viridian Therapeutics, Inc.\DE	6,267	—
03 Mar 2026	TAX_WITHHOLDING	Viridian Therapeutics, Inc.\DE	2,091	29.32 USD
02 Mar 2026	GRANT_AWARD	Viridian Therapeutics, Inc.\DE	102,850	0.00 USD	deriv
03 Mar 2026	EXERCISE	Viridian Therapeutics, Inc.\DE	6,267	0.00 USD	deriv

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Viridian Therapeutics, Inc.\DE	18,801	reported	03 Mar 2026	tx 9+575,142−10,389

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
03 Mar 2026	EXERCISE	Viridian Therapeutics, Inc.\DE	6,267	—
03 Mar 2026	TAX_WITHHOLDING	Viridian Therapeutics, Inc.\DE	2,091	29.32 USD
02 Mar 2026	GRANT_AWARD	Viridian Therapeutics, Inc.\DE	102,850	0.00 USD	deriv
03 Mar 2026	EXERCISE	Viridian Therapeutics, Inc.\DE	6,267	0.00 USD	deriv